From Clinical AI Alerts to Clinical Action in Viet Nam: Building Closed-Loop Response, Escalation and Follow-Up
PRACTICAL FRAMEWORKS & TOOLS
From Clinical AI Alerts to Clinical Action in Viet Nam: Building Closed-Loop Response, Escalation and Follow-Up
PRACTICAL FRAMEWORKS & TOOLS
Last reviewed: 8 October 2026
A clinical AI system may identify a patient at risk, generate an accurate warning and deliver that warning to a hospital's information system. Yet the patient may still experience delayed assessment or treatment.
Consider a patient admitted to a general medical ward. An AI-based early warning system identifies an increased risk of clinical deterioration and generates an alert. The warning appears on a dashboard, but the responsible nurse is attending another patient. The doctor on duty does not receive a direct notification, and the alert remains visible without a documented clinical response.
The AI may have performed as intended, but the clinical response process has not worked as expected. This illustrates an important distinction in responsible healthcare AI implementation: detecting a potential clinical problem is not the same as ensuring that the problem is appropriately assessed and addressed.
Healthcare organizations often evaluate AI through measures such as sensitivity, specificity, predictive performance and technical reliability. These measures matter, but they do not establish whether an AI-generated warning reaches the right professional, receives timely attention or leads to an appropriate clinical decision.
For AI systems that generate clinically significant alerts, healthcare organizations need to consider the entire process from detection to clinical response and follow-up. This is the focus of closed-loop clinical AI alert management.
The central question is straightforward: When AI identifies a potential patient-safety concern, how does the organization know that someone has taken responsibility for reviewing it and that any necessary action or follow-up has been addressed?
An alert is not a clinical action
Clinical AI alerts serve different purposes. Some identify possible deterioration, while others highlight suspicious imaging findings, suggest diagnostic follow-up, indicate potential medication-related problems or identify patients who may benefit from additional assessment.
An alert may be clinically useful without representing a confirmed diagnosis. A prediction of increased deterioration risk does not establish that deterioration has occurred. A suspicious imaging flag does not replace the radiologist's interpretation. A notification about a potential medication problem does not automatically determine the correct treatment.
The appropriate response depends on the alert's intended purpose, supporting evidence, clinical context and the patient's current condition. An AI warning may justify immediate assessment, additional investigation, routine follow-up or no further action after professional review.
Healthcare organizations should therefore distinguish between generating an alert, communicating it to a responsible professional, assessing its clinical significance and carrying out any necessary action or follow-up.
A system can generate alerts accurately while the healthcare organization remains unable to demonstrate that important warnings are being handled effectively. This is not simply an algorithm-performance problem. It is a problem of clinical operations, communication and accountability.
What does closed-loop response mean in clinical AI?
Closed-loop communication is an established concept in healthcare quality and patient safety. It is particularly relevant to diagnostic test results, referrals and other situations where important clinical information must be communicated, reviewed and acted upon.
The U.S. Agency for Healthcare Research and Quality (AHRQ) has identified failures in diagnostic communication and follow-up as important patient-safety concerns [8]. Research by Dalal and colleagues also highlights why acknowledging a clinically significant test result is not necessarily sufficient to ensure that appropriate clinical actions follow [10].
These principles provide a useful foundation for managing AI-generated clinical alerts. However, clinical AI introduces additional considerations because an alert may represent a prediction, probability, recommendation or automatically identified pattern rather than a confirmed diagnostic result.
For practical purposes, closed-loop clinical AI response can be understood as a process in which a clinically relevant alert reaches an accountable recipient, receives appropriate professional assessment, leads to a documented clinical disposition and remains connected to any necessary action or follow-up until the related responsibility has been appropriately fulfilled.
The organization should also be able to recognize when an alert has not been delivered, acknowledged, assessed or addressed within the expected timeframe.
Closed-loop management does not mean that every AI alert must lead to treatment. It means that alerts requiring clinical attention should not disappear into the workflow without appropriate consideration. Nor does it mean that AI automatically makes or executes treatment decisions. The approach discussed here concerns organizational control over clinical communication, professional decision-making and follow-up, not autonomous clinical decision-making by AI.
Why this matters under Viet Nam's current healthcare and AI framework
Viet Nam's Law No. 134/2025/QH15 on Artificial Intelligence has been effective since 1 March 2026. Article 4 establishes human-centred principles, including maintaining human authority, responsibility and the capacity to intervene in AI-supported activities [1].
Article 6 is particularly relevant to healthcare. It requires stricter risk management appropriate to essential sectors that directly affect life, health and other protected interests. For healthcare, the Law specifically refers to patient safety, reliability under real-world conditions and protection of health data [1].
Decree No. 142/2026/NĐ-CP, effective since 1 May 2026, provides further requirements concerning AI risk classification, management, conformity assessment, transparency and incident handling. Article 15 establishes specific risk-management obligations for legally classified high-risk AI systems, including measures related to human oversight, monitoring and the control of emerging risks during deployment and operation [2].
These obligations must be understood within their applicable scope. They should not automatically be presented as identical legal requirements for every AI application used in healthcare.
Decision No. 33/2026/QĐ-TTg, effective since 15 August 2026, establishes Viet Nam's current list of high-risk AI systems. Its healthcare-specific entries concern defined AI-assisted surgical and robotic-surgery systems meeting particular conditions [3].
Other AI systems that generate clinically important warnings may fall outside those entries. This does not establish that their clinical risks are necessarily low or that failures in clinical response are inconsequential.
The Law on Medical Examination and Treatment provides a broader foundation for professional responsibility and patient safety. Article 62 addresses clinical examination, treatment decisions and prescribing, including the responsibility of assigned healthcare practitioners to make timely and accurate professional decisions and remain accountable for them. Article 71 establishes an approach to preventing medical incidents through identification, reporting, analysis of causes and preventive measures intended to avoid recurrence and improve healthcare quality and patient safety [4].
Circular No. 19/2013/TT-BYT also establishes hospital quality management as an ongoing organizational responsibility [5].
These provisions support the importance of safe clinical processes and professional accountability. However, they do not establish a universal AI alert-response model, prescribe standardized response times for all clinical AI alerts or require healthcare organizations to adopt the framework proposed in this article.
Closed-loop clinical AI alert management should therefore be understood as a practical organizational approach that supports broader patient-safety responsibilities, while applicable legal obligations must still be assessed for each system and clinical use.
Decide which AI alerts require a managed response
Not every AI output needs the same response process. A system may produce continuous risk estimates, informational prompts, workflow suggestions or warnings requiring urgent attention. Applying one escalation process to every output may overwhelm staff and make genuinely important alerts harder to recognize.
Before designing the workflow, the healthcare organization should determine which outputs are intended to prompt clinical assessment or action.
A deterioration alert identifying a patient who may need urgent reassessment has different implications from a reminder to review a routine administrative task. An AI-generated flag suggesting a potentially important radiological finding may need to be managed through an established diagnostic reporting process. A predictive score may inform clinical judgment without requiring a separate notification every time it changes.
The appropriate response should reflect the alert's intended purpose, the potential consequences of delay, the supporting evidence and the organization's ability to respond.
It may be useful to distinguish alerts requiring immediate attention, those needing time-sensitive clinical review and notifications that can be incorporated into routine work. These are practical operational distinctions, not statutory AI risk categories.
The organization should also clarify whether an alert is intended to initiate a new clinical response, support an existing process or provide additional information for a decision already underway. This helps avoid creating unnecessary tasks every time an AI system produces an output.
Importantly, the absence of an AI alert should not automatically be interpreted as evidence that a patient is safe. Clinical assessment must continue according to the patient's condition, established care processes and professional judgment, whether or not an AI warning appears.
Who is responsible for receiving and reviewing the alert?
One of the most important questions in closed-loop management is also one of the simplest: Who is responsible for receiving the alert?
An AI system may successfully transmit a warning to an electronic medical record, dashboard or notification service. That does not necessarily establish that the appropriate healthcare professional has received or reviewed it.
The organization needs to distinguish technical delivery from accountable clinical receipt.
Consider an alert generated for a patient admitted to a medical ward. It may be directed to a shared nursing dashboard, the attending physician's electronic inbox or a departmental notification system. Each arrangement has different implications for timely response.
If the warning is delivered to a shared account, responsibility may become unclear. If it is sent to a clinician who is no longer on duty, the alert may remain unread. If notifications depend on a single mobile device, technical or connectivity problems may interrupt delivery.
For clinically significant alerts, organizations should identify a responsible recipient or clinical role and establish what happens when that person is unavailable.
The appropriate recipient depends on the clinical task. A warning may initially require nursing assessment, direct medical review, specialist interpretation or immediate escalation through an existing emergency-response process. The system should support these professional responsibilities rather than assign accountability solely according to who happens to have access to the software.
A reliable process also needs to reflect shift schedules, overnight coverage, weekends and changes in the patient's location or treating team.
An alert is not reliably communicated simply because it exists somewhere in the hospital's information system.
Acknowledgment, assessment and action are different steps
Many digital systems include an acknowledgment function. A clinician may click a button to confirm that an alert has been seen or received.
This can be useful, but acknowledgment should not be confused with clinical assessment.
A nurse may acknowledge a deterioration alert while arranging to assess the patient. A physician may acknowledge an imaging notification but still need to review the images and formal report. A pharmacist may acknowledge a medication-related warning before checking the patient's treatment history and current prescriptions.
In each case, the alert has been received, but the clinical process may still be incomplete.
Healthcare organizations should therefore define what acknowledgment means. Does it confirm technical receipt, indicate that a professional has accepted responsibility or establish that a clinical assessment has occurred? These are different states and should not be treated as interchangeable.
For alerts with meaningful patient-safety implications, it may be useful to distinguish delivered, acknowledged, clinically assessed, action or follow-up pending, and resolved.
These distinctions can be incorporated into existing clinical records, electronic task-management systems or other appropriately controlled processes. They do not necessarily require a new software platform.
Once an alert has been reviewed, the next step is to determine its clinical significance. The AI output should be considered alongside the patient's current condition, clinical observations, examination findings, laboratory results, imaging and other relevant information.
A deterioration warning may prompt bedside reassessment. The clinician may identify a genuine problem requiring escalation, determine that additional observations are needed or conclude that the warning does not indicate an immediate concern.
Each outcome may be appropriate in its clinical context.
Closed-loop management should not pressure professionals to accept every AI recommendation merely to demonstrate compliance with a digital workflow. Such an approach could encourage unnecessary investigations, inappropriate treatment or overreliance on AI.
Instead, the organization should support a clear clinical disposition: an appropriately documented decision about what, if anything, needs to happen next.
A clinician may act on the warning, arrange further assessment, seek specialist advice, defer a decision pending additional information or decide that no additional intervention is necessary after clinical review. Where the decision has important patient-safety implications, the rationale should be documented proportionately.
The objective is not to maximize AI recommendation acceptance. It is to ensure that clinically important alerts receive appropriate professional assessment and accountable follow-through.
Escalation is needed when the response process is at risk of failing
Escalation is often discussed as something that happens when a patient's condition deteriorates. In AI-enabled workflows, it may also be needed when an important warning has not received the expected response.
An alert may remain unacknowledged because the assigned recipient is unavailable, the notification has not reached the intended person or the responsible team is managing competing clinical priorities. If the organization has no agreed process for these situations, an alert can remain unresolved even when the AI is technically functioning correctly.
For warnings requiring time-sensitive clinical review, healthcare organizations should establish when and how an unresolved notification is escalated.
Depending on the clinical situation, this may involve notifying another qualified professional, contacting the doctor on duty, using an existing rapid-response process or arranging direct verbal communication for urgent concerns.
The escalation pathway should distinguish between failure to deliver an alert, failure to acknowledge it, failure to complete the necessary assessment and failure to carry out an agreed follow-up action.
These situations may require different responses. A warning that has not reached anyone may require technical troubleshooting and an immediate alternative means of communication. An alert acknowledged but not assessed may require reassignment or clinical escalation. A completed assessment with outstanding follow-up requires continued tracking of the clinical task.
Response expectations should reflect the potential consequences of delay, the patient's condition, the alert's intended purpose and the service's actual capacity.
There is no single response-time threshold suitable for every clinical AI alert. A warning of possible acute deterioration and a reminder about nonurgent diagnostic follow-up should not necessarily have the same timeframe.
Where binding professional or service-specific response requirements apply, those requirements must be followed. Other local response targets should be clinically justified, documented and tested under realistic working conditions.
An escalation pathway is not reliable if it routinely transfers unresolved alerts to another professional who is also unable to respond. The organization therefore needs to consider not only who receives an escalated warning but whether that person or team has the information, authority and capacity to act.
Closing an alert is not always the same as completing follow-up
An alert should not automatically be considered resolved because someone has viewed it, acknowledged it or entered a brief note.
For clinically actionable warnings, the organization needs to understand whether the required assessment, decision or follow-up has been appropriately addressed.
Suppose an AI-supported imaging system identifies a finding that requires radiologist review. The radiologist evaluates the images and determines that further investigation is necessary. The relevant treating clinician must then receive the information, assess its significance and arrange appropriate next steps.
The AI notification is only the beginning of that process.
Similarly, an AI-based deterioration warning may lead to reassessment and a decision to increase monitoring, obtain urgent medical review or initiate another appropriate intervention. The workflow should distinguish the original notification from the resulting clinical response.
Sometimes the appropriate clinical decision is to take no additional action. If a qualified professional has reviewed the information, considered the patient's circumstances and determined that further intervention is unnecessary, the alert may be closed with suitable documentation.
In other situations, the initial alert review may be complete while an associated clinical task remains outstanding. The patient may need another test, specialist consultation or follow-up appointment.
Closing the initial alert must not make an unfinished clinical responsibility disappear.
A healthcare organization may choose to close the notification component once an appropriate disposition has been documented and a follow-up task has been created. However, the associated task should remain visible and assigned until it is completed or transferred through an agreed process.
A transfer of responsibility should involve a clearly identified receiving professional or team and, where appropriate, confirmation that the responsibility has been accepted.
Simply forwarding a message or changing an electronic status does not necessarily establish that follow-up has been secured.
Organizations should distinguish alert disposition, transfer of responsibility and completion of the required clinical follow-up. These represent different stages of the process.
A closed-loop system should allow the organization to account for the status of important follow-up activities, even when they continue beyond the original AI notification. This does not guarantee a particular clinical outcome, but it provides reasonable assurance that significant information has not been lost between detection, professional judgment and continuing care.
A practical Clinical AI Alert Response and Escalation Matrix
Healthcare organizations in Viet Nam can translate these principles into a Clinical AI Alert Response and Escalation Matrix.
This is proposed as a practical organizational tool rather than a prescribed Vietnamese regulatory form or an international certification requirement.
The matrix should clarify how each category of clinically important AI alert moves from notification to professional assessment, clinical disposition and necessary follow-up. It can be incorporated into existing clinical protocols, electronic systems or quality-management processes.
For each relevant alert category, the organization should identify the system's intended clinical purpose, the patient population and care setting, the meaning of the warning and the potential consequences of delayed attention.
It should then identify the primary responsible recipient, an appropriate backup recipient, the communication method and the conditions that require escalation.
The matrix should also define clinically justified response expectations, the type of professional assessment required, possible clinical dispositions and the conditions for closing the notification or completing associated follow-up tasks.
Documentation should remain proportionate to risk. Useful information may include the alert time, patient or encounter identifier, responsible recipient, acknowledgment, clinical assessment, disposition, escalation where necessary and the status of any outstanding action.
For example, a hospital using an AI-based deterioration alert on an inpatient ward might assign initial assessment to the responsible nurse, with medical escalation based on the patient's condition and established hospital procedures. If the nurse cannot receive or assess an urgent warning, the process should identify another qualified professional who can assume that responsibility.
After assessment, the record should indicate the resulting decision, such as increased observation, medical review, another clinical intervention or no further action with an appropriate rationale.
If follow-up remains necessary, the related task should stay visible to the responsible team until it is completed or transferred through an accepted and traceable process.
The matrix should also address situations where the patient has moved to another department, the original clinician has ended a shift or a notification has been generated outside normal service hours.
Hospitals should not copy response targets from another organization without considering their own clinical services, staffing arrangements and operational capabilities. A small specialty clinic and a large hospital providing continuous inpatient care may need different arrangements, even when using similar AI technology.
The value of the matrix is not its complexity. It is the clarity it creates about who receives an alert, what response is expected, when escalation is necessary and how the organization determines whether important clinical responsibilities have been fulfilled.
Handover and technical reliability are essential
Clinical responsibility changes throughout the patient journey. A patient may move between departments, a shift may end, another doctor may assume care or an outpatient may leave the facility before an important result becomes available.
AI-generated alerts can become difficult to manage during these transitions.
A deterioration warning generated near the end of a nursing shift may be acknowledged but not fully assessed before handover. A diagnostic finding identified after an outpatient consultation may enter an electronic inbox monitored by a clinician who is unavailable. An alert may remain assigned to the original department after the patient has been transferred.
Closed-loop management should therefore include a practical method for transferring outstanding alert-related responsibilities.
A handover should establish what information has been received, what assessment or action has already occurred, what remains unresolved and who is responsible for the next step.
For time-critical concerns, electronic documentation alone may not provide sufficient assurance that the receiving team is aware of the situation. Direct communication may be necessary, depending on the clinical circumstances.
Technical reliability also matters. An alert may be generated but fail to reach the intended recipient because of an interface problem, network interruption, delayed synchronization, incorrect patient association or notification configuration. A warning may also appear in one application without being successfully transferred to the clinical communication or task-management platform.
These failures may be difficult to detect when monitoring focuses only on whether the AI model is operating.
For clinically important alerts, healthcare organizations should understand how notification delivery is verified, what happens when delivery fails and whether undelivered or unresolved messages can be identified.
The organization should also consider duplicated, delayed or outdated alerts. A warning based on an earlier patient condition may be less relevant by the time it reaches the clinician, while repeated identical notifications may make new information harder to recognize.
Information about the alert's timing, patient association and clinical context should therefore be available where necessary for interpretation.
Where a notification system cannot reliably demonstrate delivery and acknowledgment, the organization should be cautious about using it as the sole communication method for time-critical clinical information. Appropriate alternative communication and clinical response arrangements should be available according to the relevant risks.
Patient communication and follow-up also matter
Some AI-generated warnings lead to decisions that require communication with patients or caregivers.
An AI-supported diagnostic process may identify a finding requiring further assessment after the patient has left the healthcare facility. The patient may need to be contacted, informed of the relevant clinical recommendation and offered an appropriate follow-up arrangement.
A message sent to a patient does not automatically establish that the information was understood or that the necessary follow-up occurred.
The organization should consider who communicates important findings, how contact attempts are documented, what happens when the patient cannot be reached and how unresolved follow-up is managed.
AI-generated predictions or findings should not be communicated as confirmed diagnoses unless the available clinical evidence and professional assessment support that conclusion.
Patient communication should remain clinically appropriate and sensitive to uncertainty. The organization should also consider the patient's ability to understand and respond to the information, including language, communication needs and practical barriers to follow-up.
Privacy and confidentiality remain important. Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and Decree No. 356/2025/NĐ-CP have been effective since 1 January 2026 [6, 7].
Where AI alerts contain identifiable patient information, healthcare organizations must consider applicable requirements for processing, access, sharing and protection of personal data.
This is particularly relevant when notifications are transmitted through mobile applications, external platforms, messaging services or systems operated by third-party providers.
Convenient communication should not become a reason to bypass appropriate information-security or patient-confidentiality safeguards.
Test and monitor the clinical response, not only the AI model
A hospital may complete technical validation of an AI system without adequately testing what happens after an alert appears.
Before routine deployment of clinically important warnings, the organization should examine whether the response workflow functions under realistic clinical conditions.
This is best approached as an operational exercise involving the professionals expected to receive, assess and act on notifications.
A scenario might involve an urgent alert arriving while the responsible clinician is occupied, a warning generated near a shift change or a notification that fails to reach its intended recipient. Other situations may include several warnings for the same patient, an alert directed to the wrong department or a warning that requires reassessment but not immediate treatment.
Teams should examine whether the alert reaches the correct professional, whether responsibility is clear, whether the expected clinical response is achievable and whether outstanding tasks remain visible.
These exercises may reveal weaknesses that are not apparent during software demonstrations or technical testing. Where possible, testing should reflect actual staffing arrangements, working conditions and service limitations rather than an idealized process designed solely by the implementation team.
Appropriate simulations or controlled test environments can be used without unnecessarily exposing real patient information.
This operational assessment is distinct from evaluating the AI model's predictive performance. Model evaluation asks whether AI produces sufficiently reliable outputs for its intended use. Closed-loop response testing asks whether the healthcare organization can manage clinically significant outputs safely when they require attention.
After deployment, healthcare organizations should monitor whether the response process continues to function as intended.
Counting alerts provides limited information on its own. A system producing thousands of notifications may appear active without demonstrating that clinically important concerns are being addressed appropriately.
For selected alert categories, organizations may consider measuring successful delivery to the intended recipient, acknowledgment, time from notification to clinical assessment and the proportion receiving an appropriate documented disposition.
Other useful measures include overdue alerts, failed notifications, unresolved follow-up tasks, escalation patterns and cases where significant warnings were missed or addressed late.
These indicators require careful interpretation.
A high acknowledgment rate does not necessarily mean that appropriate clinical decisions were made. A low intervention rate does not automatically indicate that alerts were ignored, particularly if clinicians reviewed the warnings and reasonably determined that intervention was unnecessary.
Similarly, a high rate of AI recommendation acceptance should not be treated as evidence of good practice by itself.
Quality monitoring should distinguish process reliability from clinical appropriateness. Selected case reviews may be needed to determine whether responses were justified and whether the resulting care was safe.
Where feasible, organizations should also examine whether response performance differs between departments, shifts, clinical teams or relevant patient groups.
Monitoring should consider unintended consequences, such as unnecessary investigations, excessive review work or delays in other clinical activities. Improving one response measure should not come at the expense of overall patient care.
Ultimately, operational indicators should be interpreted alongside relevant patient-safety and clinical outcomes. Faster acknowledgment is useful only when it contributes to timely and appropriate care.
Learning from failures and near misses
Not every failure in alert management causes patient harm. Nevertheless, failures and near misses can reveal important weaknesses in the clinical response process.
A significant alert delivered to the wrong recipient, left unresolved after handover or incorrectly marked as complete may indicate a vulnerability that deserves review.
The investigation should examine what prevented an appropriate response. Possible contributing factors include unclear responsibilities, incorrect notification routing, unrealistic response expectations, insufficient clinical coverage, technical limitations or a workflow that allows alerts to be closed before necessary actions have been addressed.
Where patient care may have been affected, the organization should determine whether clinical review or corrective action is necessary.
AI-related patient-safety incidents and near misses should be handled through applicable clinical governance and incident-management processes. Additional reporting requirements under AI legislation, medical-device regulation or other laws must be assessed when relevant.
An unacknowledged or delayed AI alert does not automatically constitute a legally reportable serious AI incident. Classification and reporting obligations depend on the circumstances, applicable definitions and relevant legal requirements.
The purpose of reviewing these events should be to understand why the response process failed and how similar problems can be prevented.
A system that repeatedly produces unresolved alerts may require changes to its communication process, clinical ownership, configuration or integration with routine care, even if the AI model continues to perform within its validated specifications.
Closed-loop governance should remain proportionate
Not every AI feature requires a formal acknowledgment and escalation workflow. The intensity of governance should reflect the clinical significance of the AI output and the consequences of delayed or inappropriate response.
A real-time AI aid used by an endoscopist during a procedure may be reviewed directly as part of the examination. It may not require a separate notification-management process for every visual detection cue.
An AI-based deterioration warning used for inpatient surveillance may require a more structured response because the system can generate an alert when the responsible professional is not directly observing the patient.
A nonurgent AI-generated follow-up recommendation may be managed through an existing clinical task system, provided responsibility and follow-up remain clear.
The objective is not to create unnecessary acknowledgments, documentation or administrative work. It is to ensure that alerts with meaningful patient-safety implications are managed through processes appropriate to their clinical role.
Organizations should also consider cumulative workload. Adding a separate closed-loop workflow for every AI application may create excessive complexity and contribute to notification burden.
Where possible, AI alert management should be integrated into established clinical communication, handover, escalation and quality-management processes.
International guidance supports the underlying safety principles
The importance of reliable clinical communication and follow-up is well established in international patient-safety literature.
AHRQ's work on diagnostic safety identifies failures in communication, test-result management and follow-up as important contributors to delayed or missed diagnoses [8].
The U.S. Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP/ONC) updated its SAFER Guides in 2025. These guides address organizational responsibilities, clinician communication, clinical decision support, test-result reporting and follow-up, as well as other aspects of electronic health record safety. The updated guidance also includes considerations relevant to AI-enabled systems [9].
Joint Commission launched its voluntary Responsible Use of AI in Healthcare (RUAIH) Certification on 1 June 2026. This organizational certification, designed for healthcare organizations in the United States, focuses on governance and safeguards for responsible AI use, including risk management, monitoring, evaluation, transparency and education [11].
CHAI's Governance Playbooks, released in May 2026, similarly emphasize integrating responsible AI controls into existing healthcare organizational processes [12].
Together, these sources reinforce the principle that safe AI implementation depends on people, workflows, organizational accountability and continuous learning, not only on technical performance.
However, none of these sources establishes the specific Clinical AI Alert Response and Escalation Matrix proposed in this article. The matrix is a practical adaptation of established patient-safety and clinical communication principles for AI-enabled healthcare workflows.
International guidance should not be confused with binding legal requirements for healthcare organizations in Viet Nam.
What healthcare organizations in Viet Nam should prioritize
Healthcare organizations do not necessarily need sophisticated new software to improve their response to clinically important AI alerts.
A practical starting point is to select one AI application with a clearly defined clinical purpose and examine how its alerts are currently received, assessed and acted upon.
The organization should establish whether responsibility is clear, whether urgent warnings can reach an appropriate professional, whether unresolved alerts remain visible and whether necessary follow-up can be traced to a documented clinical disposition.
Where existing electronic systems support these functions, the response process can be integrated into them. Where digital integration remains limited, appropriately controlled clinical records or task-management arrangements may provide an interim solution, provided confidentiality, traceability and operational reliability are maintained.
The most important improvement may be organizational rather than technical: agreeing who is responsible, what constitutes an appropriate response, when escalation is necessary and how the team will recognize when a clinically important alert has not been adequately addressed.
Clinical leadership should be involved because these decisions affect patient care and professional responsibilities. Quality and patient-safety teams can help evaluate reliability, while information technology personnel and relevant providers can support notification delivery and technical safeguards.
Responsibility for maintaining the workflow should be clear, but this does not necessarily require a separate AI-specific committee.
The organization should also recognize that closed-loop processes need to evolve as services, staffing arrangements, technology and clinical practices change. A workflow that functions well during initial implementation may become less reliable when patient volume increases, staff roles change or additional systems are introduced.
For healthcare leaders, the practical question is not simply whether the hospital has an AI system capable of detecting clinical risk. It is whether the organization can demonstrate a reliable connection between clinically important AI warnings, accountable professional assessment and appropriate patient care.
From detecting risk to managing the clinical response
AI has the potential to help healthcare organizations recognize clinical problems earlier, prioritize attention and support better-informed decisions. But early detection alone does not ensure better patient care.
A reliable AI alert is only one part of a safe clinical process. Healthcare organizations also need to determine who receives the warning, what professional assessment is required, when escalation becomes necessary and how outstanding clinical responsibilities are followed through.
Closed-loop response does not require clinicians to accept every AI recommendation. It requires the organization to ensure that clinically important alerts are appropriately considered and that necessary actions do not disappear between technology and care delivery.
This represents an important transition in responsible healthcare AI implementation:
from generating alerts → to ensuring clinical review → to completing appropriate action and follow-up
The objective is not to produce more notifications, achieve more acknowledgment clicks or demonstrate higher AI usage. It is to help healthcare professionals identify and address important patient needs in a timely, safe and accountable manner.
Ultimately, the value of a clinical AI alert depends not only on whether it identifies a potential problem, but also on whether the healthcare organization can respond to that information appropriately and safely.
Professional education notice
This article is intended for professional education and knowledge exchange. It does not constitute individualized legal, regulatory, clinical, patient-safety, medical-device, cybersecurity, personal-data-protection, accreditation or quality-management advice.
The terms closed-loop clinical AI response and Clinical AI Alert Response and Escalation Matrix are used in this article as practical organizational concepts. They are not defined statutory categories or prescribed documentation requirements under Vietnamese law.
The approach proposed here is not a Ministry of Health framework, a statutory AI response-time requirement, a Joint Commission standard, a CHAI framework or an AHRQ guideline specifically governing clinical AI alerts.
Applicable legal obligations must be assessed according to the relevant AI system, clinical use and circumstances, including requirements concerning professional responsibility, patient safety, AI risk classification, medical-device regulation, personal-data protection, incident reporting and other applicable laws.
AHRQ, ASTP/ONC, Joint Commission and CHAI materials are used as international reference points for patient safety, organizational governance and responsible implementation. They do not themselves create binding legal obligations for healthcare organizations in Viet Nam.
References
National Assembly of Viet Nam. Law No. 134/2025/QH15 on Artificial Intelligence. Adopted 10 December 2025; effective 1 March 2026.
Government of Viet Nam. Decree No. 142/2026/NĐ-CP Detailing a Number of Articles and Measures for Implementation of the Law on Artificial Intelligence. Issued 30 April 2026; effective 1 May 2026.
Prime Minister of Viet Nam. Decision No. 33/2026/QĐ-TTg Promulgating the List of High-Risk Artificial Intelligence Systems. Issued 30 June 2026; effective 15 August 2026.
National Assembly of Viet Nam. Law No. 15/2023/QH15 on Medical Examination and Treatment, as amended. Effective 1 January 2024. Consolidated Document No. 26/VBHN-VPQH, issued by the Office of the National Assembly on 26 February 2026.
Ministry of Health of Viet Nam. Circular No. 19/2013/TT-BYT Providing Guidance on Management of Quality of Medical Examination and Treatment Services in Hospitals. Issued 12 July 2013; effective 15 September 2013.
National Assembly of Viet Nam. Law No. 91/2025/QH15 on Personal Data Protection. Adopted 26 June 2025; effective 1 January 2026.
Government of Viet Nam. Decree No. 356/2025/NĐ-CP Detailing a Number of Articles and Measures for Implementation of the Law on Personal Data Protection. Issued 31 December 2025; effective 1 January 2026.
Khan S, Cholankeril R, Sloane J, et al. Current State of Diagnostic Safety: Implications for Research, Practice, and Policy. Agency for Healthcare Research and Quality. January 2024. Publication No. 24-0010-1-EF.
Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology (ASTP/ONC). 2025 SAFER Guides. Including Organizational Responsibilities, Clinician Communication, Computerized Provider Order Entry with Decision Support, and Test Results Reporting and Follow-Up. Published 2025.
Dalal AK, Pesterev BM, Eibensteiner K, et al. Linking Acknowledgement to Action: Closing the Loop on Non-Urgent, Clinically Significant Test Results in the Electronic Health Record. Journal of the American Medical Informatics Association. 2015;22(4):905–908. DOI: 10.1093/jamia/ocv007.
Joint Commission. Responsible Use of AI in Healthcare Certification. Launched 1 June 2026.
Coalition for Health AI (CHAI). AI Governance Playbooks. Released 27 May 2026.